{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:02:15Z","timestamp":1792152135604,"version":"4.4.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"2-4","license":[{"start":{"date-parts":[[1997,12,1]],"date-time":"1997-12-01T00:00:00Z","timestamp":880934400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Lab Res"],"published-print":{"date-parts":[[1997,12]]},"DOI":"10.1007\/bf02912462","type":"journal-article","created":{"date-parts":[[2008,5,31]],"date-time":"2008-05-31T11:27:05Z","timestamp":1212233225000},"page":"225-232","source":"Crossref","is-referenced-by-count":27,"title":["Beh\u00e7et\u2019s disease: an immune-mediated vasculitis involving vessels of all sizes"],"prefix":"10.1007","volume":"27","author":[{"given":"R.","family":"Rizzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dammacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02912462_CR1","first-page":"871","volume-title":"Trattato di Medicina Interna","author":"F Dammacco","year":"1993","unstructured":"Dammacco F. Malattia di Beh\u00c7et (Sindrome muco-cutanea-oculare). In: Teodori U, Gentilini R eds. Trattato di Medicina Interna. Roma: Societ\u00e0 Editrice Universo; 1993:871\u2013873."},{"key":"BF02912462_CR2","first-page":"341","volume":"19","author":"JT Lie","year":"1992","unstructured":"Lie JT. Vascular involvement in Beh\u00c7et\u2019s disease: arterial and venous and vessels of all sizes. J Rheumatol 1992; 19:341.","journal-title":"J Rheumatol"},{"key":"BF02912462_CR3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000253787","volume":"81","author":"H Beh\u00c7et","year":"1940","unstructured":"Beh\u00c7et H. Some observations on the clinical picture of the so-called triple symptom complex. Dermatologica 1940; 81:73.","journal-title":"Dermatologica"},{"key":"BF02912462_CR4","first-page":"403","volume":"III","author":"S Adams","year":"1849","unstructured":"Adams S. The genuine works of Hippocrates. Translated from Greek. A preliminary discourse and annotations. Epidemics III 1849:403.","journal-title":"Epidemics"},{"key":"BF02912462_CR5","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJM199002013220509","volume":"322","author":"JD O\u2019Duffy","year":"1990","unstructured":"O\u2019Duffy JD. Beh\u00c7et\u2019s syndrome. N Engl J Med 1990; 322:326.","journal-title":"N Engl J Med"},{"key":"BF02912462_CR6","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2249.1990.tb05447.x","volume":"82","author":"F Fortune","year":"1990","unstructured":"Fortune F, Walker J, Lehener T. The expression of \u03b3\u03b4 T cell receptor and the prevalence of primed, activated and IgA-bound T cells in Beh\u00c7et\u2019s syndrome. Clin Exp Immunol 1990; 82:326.","journal-title":"Clin Exp Immunol"},{"key":"BF02912462_CR7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00002281-199305010-00008","volume":"5","author":"NB Allen","year":"1993","unstructured":"Allen NB. Miscellaneous vasculitis syndromes including Beh\u00c7et\u2019s disease and central nervous system vasculitis. Curr Opin Rheumatol 1993; 5:51.","journal-title":"Curr Opin Rheumatol"},{"key":"BF02912462_CR8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00002281-199401000-00007","volume":"6","author":"JD O\u2019Duffy","year":"1994","unstructured":"O\u2019Duffy JD. Beh\u00c7et\u2019s disease. Curr Opin Rheumatol 1994;6:39.","journal-title":"Curr Opin Rheumatol"},{"key":"BF02912462_CR9","first-page":"607","volume":"63","author":"N Mizuki","year":"1996","unstructured":"Mizuki N, Ohno S. Immunogenetic studies of Beh\u00c7et\u2019s disease. Rev Rhum Engl Ed 1996; 63:607.","journal-title":"Rev Rhum Engl Ed"},{"key":"BF02912462_CR10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1399-0039.1992.tb01925.x","volume":"39","author":"A Balboni","year":"1992","unstructured":"Balboni A, Pivetti-Pezzi P, Orlando P, Rubini M, Selvatici R, Accorinti M, Baricordi OR, Gandini E. Serological and molecular HLA typing in Italian Beh\u00c7et\u2019s patients: significant association of B51-DR5-DQw3 haplotype. Tissue Antigens 1992; 39:141.","journal-title":"Tissue Antigens"},{"key":"BF02912462_CR11","first-page":"20","volume":"12","author":"L Emmi","year":"1997","unstructured":"Emmi L, Brugnolo F, Marchione T. Pathogenesis and therapy of Beh\u00c7et\u2019s disease. Ann Ital Med Int 1997; 12:20.","journal-title":"Ann Ital Med Int"},{"key":"BF02912462_CR12","first-page":"588","volume":"19","author":"Y Suzuki","year":"1992","unstructured":"Suzuki Y, Hoshi K, Matsuda T, Mizushima Y. Increased peripheral blood \u03b3\u03b4 T cells and natural killer cells in Beh\u00c7et\u2019s disease. J Rheumatol 1992; 19:588.","journal-title":"J Rheumatol"},{"key":"BF02912462_CR13","first-page":"2301","volume":"21","author":"K Hamzaoui","year":"1994","unstructured":"Hamzaoui K, Hamzaoui A, Hentati F, Kahan A, Ayed K, Chabbou A, Ben Hamida M, Hamza M\u2019H. Phenotype and functional profile of T cells expressing \u03b3\u03b4 receptor patients with active Beh\u00c7et\u2019s disease. J Rheumatol 1994; 21:2301.","journal-title":"J Rheumatol"},{"key":"BF02912462_CR14","first-page":"742","volume":"19","author":"A Kahan","year":"1992","unstructured":"Kahan A, Hamzaoui K, Ayet K. Abnormalities of T lymphocyte subsets in Beh\u00c7et\u2019s disease demonstrated with anti-CD45RA and anti-CD29 monoclonal antibodies. J Rheumatol 1992; 19:742.","journal-title":"J Rheumatol"},{"key":"BF02912462_CR15","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.4049\/jimmunol.142.6.1785","volume":"142","author":"JA Bluestone","year":"1989","unstructured":"Bluestone JA, Matis LA. TCR gamma delta cellsminor redundant T cell subset or specialized immune system component? J Immunol 1989; 142:1785.","journal-title":"J Immunol"},{"key":"BF02912462_CR16","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1126\/science.1828619","volume":"252","author":"WL Havran","year":"1991","unstructured":"Havran WL, Chien Y-H, Allison JP. Recognition of self antigens by skin-derived T cells with invariant \u03b3\u03b4 antigen receptors. Science 1991; 252:1430.","journal-title":"Science"},{"key":"BF02912462_CR17","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.7973709","volume":"266","author":"R Boismenu","year":"1994","unstructured":"Boismenu R, Havran WL. Modulation of epithelial cell growth by intraepithelial \u03b3\u03b4 T cells. Science 1994; 266:1253.","journal-title":"Science"},{"key":"BF02912462_CR18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/bjo.76.8.499","volume":"76","author":"DG Charteries","year":"1992","unstructured":"Charteries DG, Champ C, Rosenthal AR, Lightman SL. Beh\u00c7et\u2019s disease: activated T lymphocytes in retinal perivasculitis. Br J Ophthalmol 1992; 76:499.","journal-title":"Br J Ophthalmol"},{"key":"BF02912462_CR19","first-page":"227","volume":"9","author":"L Pronai","year":"1991","unstructured":"Pronai L, Ichikawa Y, Nakazawa H, Arimori S. Enhanced superoxide generation and the decreased Superoxide scavenging activity of peripheral blood leukocytes in Beh\u00c7et\u2019s disease-effects of colchicine. Clin Exp Rheumatol 1991; 9:227.","journal-title":"Clin Exp Rheumatol"},{"key":"BF02912462_CR20","first-page":"1544","volume":"20","author":"J-L Mege","year":"1993","unstructured":"Mege J-L, Dilsen N, Sanguedolce V, Gul A, Bongrand P, Roux H, Ocal L, Inan\u00c7 M, Capo C. Overproduction of monocyte derived tumor necrosis factor \u03b1 interleukin (IL) 6, IL-8 and increased neutrophil Superoxide generation in Beh\u00c7et\u2019s disease. A comparative study with Familial Mediterranean Fever and healthy subjects. J Rheumatol 1993; 20:1544.","journal-title":"J Rheumatol"},{"key":"BF02912462_CR21","first-page":"852","volume":"16","author":"K Hamzaoui","year":"1989","unstructured":"Hamzaoui K, Ayed K. Soluble interleukin-2 receptors in patients with Beh\u00c7et\u2019s disease. J Rheumatol 1989; 16:852.","journal-title":"J Rheumatol"},{"key":"BF02912462_CR22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0002-9394(14)73520-2","volume":"115","author":"D BenEzra","year":"1993","unstructured":"BenEzra D, Maftzir G, Kalichman I, Barak V. Serum levels of interleukin-2 receptor in ocular Beh\u00c7et\u2019s disease. Am J Ophthalmol 1993; 115:26.","journal-title":"Am J Ophthalmol"},{"key":"BF02912462_CR23","first-page":"1107","volume":"17","author":"TF Akoglu","year":"1990","unstructured":"Akoglu TF, Direskeneli H, Yazici H, Lawrence R. TNF, soluble IL-2R and soluble CD-8 in Beh\u00c7et\u2019s disease. J Rheumatol 1990; 17:1107.","journal-title":"J Rheumatol"},{"key":"BF02912462_CR24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2249.1990.tb05122.x","volume":"79","author":"K Hamzaoui","year":"1990","unstructured":"Hamzaoui K, Ayed K, Slim A, Hamza M, Touraine J. Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Beh\u00c7et\u2019s disease. Clin Exp Immunol 1990; 79:28.","journal-title":"Clin Exp Immunol"},{"key":"BF02912462_CR25","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.4049\/jimmunol.130.4.1683","volume":"130","author":"N Fujii","year":"1983","unstructured":"Fujii N, Minagawa T, Nakano A. Spontaneous production of gamma-interferon in culture of T lymphocytes obtained from patients with Beh\u00c7et\u2019s disease. J Immunol 1983; 130: 1683.","journal-title":"J Immunol"},{"key":"BF02912462_CR26","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0008-8749(92)90207-6","volume":"140","author":"S Hirohata","year":"1992","unstructured":"Hirohata S, Oka H, Mizushima Y. Streptococcal-related antigens stimulate production of IL-6 and interferon-\u03b3 by T cells from patients with Beh\u00c7et\u2019s disease. Cell Immunol 1992; 140:410.","journal-title":"Cell Immunol"},{"key":"BF02912462_CR27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/clin.1993.1029","volume":"66","author":"S Hirohata","year":"1993","unstructured":"Hirohata S, Tanimoto K, Ito K. Elevation of cerebrospinal fluid interleukin-6 activity in patients with vasculitides and central nervous system involvement. Clin Immunol Immunopathol 1993: 66:225.","journal-title":"Clin Immunol Immunopathol"},{"key":"BF02912462_CR28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1155\/S0962935192000437","volume":"1","author":"K Hamzaoui","year":"1992","unstructured":"Hamzaoui K, Hamzaoui A, Kahan A, Hamza M, Chabbou A, Ayed K. Interleukin-6 in peripheral blood and inflammatory sites in Beh\u00c7et\u2019s disease. Mediat Inflamm 1992; 1:281.","journal-title":"Mediat Inflamm"},{"key":"BF02912462_CR29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/rheumatology\/35.4.357","volume":"35","author":"A Hamzaoui","year":"1996","unstructured":"Hamzaoui A, Hamzaoui K, Chabbou A, Ayed K. Endothelin-1 expression in serum and bronchoalveolar lavage from patients with active Beh\u00c7et\u2019s disease. Br J Rheumatol 1996; 35:357.","journal-title":"Br J Rheumatol"},{"key":"BF02912462_CR30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/373255a0","volume":"373","author":"DA Ferrick","year":"1995","unstructured":"Ferrick DA, Schrenzel MD, Mulvania T, Hsieh B, Ferlin WG, Lepper H. Differential production of interferon-\u03b3 and interleukin-4 in response to Th 1- and Th2-simulating pathogens by \u03b3\u03b4 T cells \u201cin vivo\u201d. Nature 1995; 373:255.","journal-title":"Nature"},{"key":"BF02912462_CR31","doi-asserted-by":"crossref","first-page":"9620","DOI":"10.1073\/pnas.90.20.9620","volume":"90","author":"SHE Kaufmann","year":"1993","unstructured":"Kaufmann SHE, Blum C, Yamamoto S. Crosstalk between\u03b1\/\u0392 T cells and \u03b3\/\u03b4 cells \u201cin vivo\u201d: activation of \u03b1\/\u0392 T cell responses after \u03b3\/\u03b4T modulation with the monocolonal antibody GL3. Proc Natl Acad Sci USA 1993; 90:9620.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02912462_CR32","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-2133.1995.tb16946.x","volume":"132","author":"A Gul","year":"1995","unstructured":"Gul A, Esin S, Dilsen N, Konicz M, Wigzell H, Biberfeld P. Irnmunohistology of skin pathergy reaction in Beh\u00c7et\u2019s disease. Br J Dermatol 1995; 132:901.","journal-title":"Br J Dermatol"},{"key":"BF02912462_CR33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0002-9343(96)00230-6","volume":"101","author":"MWJ Boehme","year":"1996","unstructured":"Boehme MWJ, Schmitt WH, Youinou P, Stremmel WR, Gross WL. Clinical relevance of elevated serum thrombomodulin and soluble E-selection in patients with Wegener\u2019s granulomatosis and other systemic vasculitides. Am J Med 1996; 101:387.","journal-title":"Am J Med"},{"key":"BF02912462_CR34","unstructured":"Rizzi R, Numo R, Bruno S, Stellacci C, Pomes L, Dammacco R. Anti-endothelial ceil antibodies (AECA) in Beh\u00c7et\u2019s disease. EJIM in press."},{"key":"BF02912462_CR35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/BF02231554","volume":"12","author":"AN Al-Daalan","year":"1993","unstructured":"Al-Daalan AN, Al-Ballaa AL, Janadi AL, Bohlega S, Bahabri S. Association of anti-cardiolipin antibodies with vascular thrombosis and neurological manifestation of Beh\u00c7et\u2019s disease. Clin Rheumatol 1993; 12:28.","journal-title":"Clin Rheumatol"},{"key":"BF02912462_CR36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2133.1993.tb00172.x","volume":"128","author":"CC Zouboulis","year":"1993","unstructured":"Zouboulis CC, B\u00fcttner P, Tebbe B, Orfanos CE. Anticardiolipin antibodies in Adamantiades-Beh\u00c7et\u2019s disease. Br J Dermatol 1993; 128:281.","journal-title":"Br J Dermatol"},{"key":"BF02912462_CR37","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/rheumatology\/33.4.406","volume":"33","author":"G Vaiopoulos","year":"1993","unstructured":"Vaiopoulos G, Hatzinikolaou P, Tsiroyanni A, Mavropoulos S, Stamatelos G, Terzoglou K, Tzonou A, Economidou I, Kaklamanis P. Anti-neutrophil cytoplasmic antibodies in Adamantiadis-Beh\u00c7et\u2019s disease. Br J Rheumatol 1993; 33:406.","journal-title":"Br J Rheumatol"},{"key":"BF02912462_CR38","first-page":"871","volume":"8","author":"CW Yang","year":"1993","unstructured":"Yang CW, Park IS, Kim SY, Chang YS, Yoon YS, Bang BK, Choi YJ, Cho SH, Suh KS, Antineutrophil cytoplasmic autoantibody associated vasculitis and renal failure in Beh\u00c7et\u2019s disease. Nephrol Dial Transplant 1993; 8:871.","journal-title":"Nephrol Dial Transplant"},{"key":"BF02912462_CR39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/clin.1993.1059","volume":"67","author":"AO Aydintug","year":"1993","unstructured":"Aydintug AO, Zokg\u00f6z G, D\u2019Cruz DP, G\u00fcrler A, Cervera R, Diizgiin N, Atmaca LS, Khamashata MA, Hughes GRV. Antibodies to endothelial cells in patients with Beh\u00c7et\u2019s disease. Clin Immunol Immunopathol 1993; 67: 157.","journal-title":"Clin Immunol Immunopathol"},{"key":"BF02912462_CR40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/ard.53.4.265","volume":"53","author":"R Cervera","year":"1994","unstructured":"Cervera R, Navarro M, L\u00f6pez-Soto A, Cid M-C, Font J, Esparza J, Reverter JC, Montegudo J, Ingelmo M, Urbano-Marquez A. Antibodies to endothelial cells in Beh\u00c7et\u2019s disease: cell-binding heterogeneity and association with clinical activity. Ann Rheum Dis 1994; 53:265.","journal-title":"Ann Rheum Dis"},{"key":"BF02912462_CR41","first-page":"260","volume":"13","author":"N Papa Del","year":"1996","unstructured":"Del Papa N, Guidali L, Radice A, Sinico RA, Moroni C, Ponticelli C, Domeneghetti MP, Farsi A, Emmi L, Tincani A, Gregorini G, Rizzi R, Passaleva A, Dammacco F, Meroni PL. Antiendothelial cell antibodies in Wegener\u2019s granulomatosis and micropolyarteritis (abstract). Sarcoidosis 1996; 13:260.","journal-title":"Sarcoidosis"},{"key":"BF02912462_CR42","first-page":"115","volume-title":"Second Symposium on Pathogenesis and Immunotherapy of Autoimmune Diseases","author":"R Rizzi","year":"1996","unstructured":"Rizzi R, Liuzzi GM, Frassanito MA, Bruno S, Cafforio P. Antiendothelial cell antibodies (AECA) in a patient with Takayasu\u2019s arteritis (abstract). Second Symposium on Pathogenesis and Immunotherapy of Autoimmune Diseases. Milano: Roche Milano Ricerche; 1996: 115."},{"key":"BF02912462_CR43","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.4049\/jimmunol.156.12.4946","volume":"156","author":"M Damianovich","year":"1996","unstructured":"Damianovich M, Gilburd B, George J, Del Papa N, Afek A, Goldberg I, Kopolovich Y, Roth D, Barkai G, Meroni PL, Shoenfeld Y. Pathogenic role of anti-endothelial cell antibodies in vasculitis. An idiotypic experimental model. J Immunol 1996; 156:4946.","journal-title":"J Immunol"},{"key":"BF02912462_CR44","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1146\/annurev.iy.11.040193.003225","volume":"11","author":"W Haas","year":"1993","unstructured":"Haas W, Pereira P, Tonegawa S. Gamma\/delta cells. Annu Rev Immunol 1993; 11:637.","journal-title":"Annu Rev Immunol"},{"key":"BF02912462_CR45","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0140-6736(96)90868-5","volume":"347","author":"A Hasan","year":"1996","unstructured":"Hasan A, Fortune F, Wilson A, Warr K, Shinnick T, Mizushima Y, Zee R van der, Stanford MR, Sanderson J, Lehner T. Role of \u03b3\u03b4 T cells in pathogenesis and diagnosis of Beh\u00c7et\u2019s disease. Lancet 1996; 347:789.","journal-title":"Lancet"},{"key":"BF02912462_CR46","first-page":"506","volume":"16","author":"The Beh\u00c7et\u2019s Disease Research Committee of Japan","year":"1989","unstructured":"The Beh\u00c7et\u2019s Disease Research Committee of Japan. Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Beh\u00c7et\u2019s disease-a multicentric study. J Rheumatol 1989; 16:506.","journal-title":"J Rheumatol"},{"key":"BF02912462_CR47","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1128\/IAI.59.4.1434-1441.1991","volume":"59","author":"T Lehner","year":"1991","unstructured":"Lehner T, Lavery E, Smith R, Zee R van der, Mizushima Y, Shinnick T. Association between the 65-kDa heat shock protein, \u201cStreptococcussanguis\u201d and the corresponding antibodies in Beh\u00c7et\u2019s syndrome. Infect Immun 1991; 59:1434.","journal-title":"Infect Immun"},{"key":"BF02912462_CR48","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/bmj.1.5538.465","volume":"1","author":"T Lehner","year":"1967","unstructured":"Lehner T. Beh\u00c7et\u2019s syndrome and autoimmunity. B M J 1967; 1:465.","journal-title":"B M J"},{"key":"BF02912462_CR49","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.4049\/jimmunol.151.4.2273","volume":"151","author":"K Pervin","year":"1993","unstructured":"Pervin K, Childerstone A, Shinnick T, Mizushima Y, Zee R van der, Hasan A, Vaughan R, Lehner T. T cell epitope expression of mycobacterial and homologous human 65-kilodalton shock protein peptides in short term cell lines from patients with Beh\u00c7et\u2019s disease. J Immunol 1993; 151:2273.","journal-title":"J Immunol"},{"key":"BF02912462_CR50","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2249.1994.tb06072.x","volume":"97","author":"MR Stanford","year":"1994","unstructured":"Stanford MR, Kasp E, Whiston R, Hasan A, Todryk S, Shinnick T, Mizushima Y, Dumonde DC, Zee R van der, Lehener T. Heat shock protein peptides in patients with Beh\u00c7et\u2019s disease are uveitogenic in Lewis rats. Clin Exp Immunol 1994; 97:226.","journal-title":"Clin Exp Immunol"},{"key":"BF02912462_CR51","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1096\/fasebj.8.15.8001742","volume":"8","author":"Y Schoenfeld","year":"1994","unstructured":"Schoenfeld Y. Idiotypic induction of autoimmunity: a new aspect of the idiotypic network. FASEB J 1994; 8:1296.","journal-title":"FASEB J"},{"key":"BF02912462_CR52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0167-5699(96)80581-0","volume":"17","author":"H Baum","year":"1996","unstructured":"Baum H, Davies H, Peakman M. Molecular mimicry in the MHC: hidden clues to autoimmunity? Immunol Today 1996; 17:64.","journal-title":"Immunol Today"},{"key":"BF02912462_CR53","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/0167-5699(96)20029-G","volume":"17","author":"S Albani","year":"1996","unstructured":"Albani S, Carson DA. A multistep molecular mimicry hypothesis for the pathogenesis of rheumatoid arthritis. Immunol Today 1996;17:466.","journal-title":"Immunol Today"},{"key":"BF02912462_CR54","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0167-5699(96)30056-X","volume":"17","author":"M Zierhut","year":"1996","unstructured":"Zierhut M, Bieber T, Br\u00f6cker E, Forrester J, Foster C, Streilein J. Immunology of the skin and the eye. Immunol Today 1996; 17:448.","journal-title":"Immunol Today"},{"key":"BF02912462_CR55","first-page":"5","volume":"12","author":"F Dammacco","year":"1997","unstructured":"Dammacco F. Malattia di Beh\u00c7et e angioedema da ACE-inibitori: due quadri morbosi poco conosciuti. Ann Ital Med Int 1997; 12:5.","journal-title":"Ann Ital Med Int"},{"key":"BF02912462_CR56","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/rheumatology\/31.11.767","volume":"31","author":"DMG Main","year":"1992","unstructured":"Main DMG, Chamberlain MA. Clinical differentiation of oral ulcerations in Beh\u00c7et\u2019s disease. Br J Rheumatol 1992; 31:767.","journal-title":"Br J Rheumatol"},{"key":"BF02912462_CR57","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2165\/00003495-199142050-00006","volume":"42","author":"H Yazici","year":"1991","unstructured":"Yazici H, Barnes CG. Practical treatment recommendations for pharmacotherapy of Beh\u00c7et\u2019s disease. Drugs 1991; 42:796.","journal-title":"Drugs"},{"key":"BF02912462_CR58","first-page":"769","volume-title":"Immunologia in medicina","author":"P Pivetti Pezzi","year":"1989","unstructured":"Pivetti Pezzi P. Patologia autoimmunitaria di interesse oculisticomalattia di Beh\u00c7et. In: Dammacco F, ed. Immunologia in medicina. Milano: Edi Ermes; 1989:769\u2013779."},{"key":"BF02912462_CR59","first-page":"402","volume":"19","author":"Y Koc","year":"1992","unstructured":"Koc Y, G\u00fcll\u00fc I, Akpek G, Akpolat T, Kansu E, Kiraz S, Batman F, Kansu T, Balkanci F, Akkaya S, Telatar H, Zileli T. Vascular involvement in Beh\u00c7et\u2019s disease. J Rheumatol 1992; 19:402.","journal-title":"J Rheumatol"},{"key":"BF02912462_CR60","first-page":"295","volume":"62","author":"MH Kallel","year":"1995","unstructured":"Kallel MH, Bejia I, Fournie B, Fournie A. Beh\u00c7et\u2019s syndrome with ankylosing spondylitis. Rev Rheum Engl Ed 1995; 62:295.","journal-title":"Rev Rheum Engl Ed"},{"key":"BF02912462_CR61","doi-asserted-by":"crossref","first-page":"651","DOI":"10.7326\/0003-4819-116-8-651","volume":"116","author":"T Lingenfelser","year":"1992","unstructured":"Lingenfelser T, Duerk H, Stevens A, Grossman T, Knorr M, Saal JG. Generalized myositis in Beh\u00c7et\u2019s disease: treatment with cyclosporine. Ann Intern Med 1992; 116:651.","journal-title":"Ann Intern Med"},{"key":"BF02912462_CR62","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00004836-199312000-00014","volume":"17","author":"MM Haber","year":"1993","unstructured":"Haber MM, Burrel M, West AB. Enterocolic lymphocytic phlebitis. Clinical, radiologic, and pathologic features. J Clin Gastroenterol 1993: 17:327.","journal-title":"J Clin Gastroenterol"},{"key":"BF02912462_CR63","first-page":"1078","volume":"335","author":"International Study Group for Beh\u00c7et\u2019s disease","year":"1990","unstructured":"International Study Group for Beh\u00c7et\u2019s disease. Criteria for diagnosis of Beh\u00c7et\u2019s disease. Lancet 1990; 335:1078.","journal-title":"Lancet"},{"key":"BF02912462_CR64","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/rheumatology\/31.5.299","volume":"31","author":"The International Study Group for Beh\u00c7et\u2019s disease","year":"1992","unstructured":"The International Study Group for Beh\u00c7et\u2019s disease. Evaluation of diagnostic (\u201cclassification\u201d) criteria in Beh\u00c7et\u2019s disease-towards internationally agreed criteria. Br J Rheumatol 1992; 31:299.","journal-title":"Br J Rheumatol"},{"key":"BF02912462_CR65","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/02713689208999534","volume":"11","author":"C Edelsten","year":"1992","unstructured":"Edelsten C, D\u2019Cruz D, Hughes GRV, Graham EM. Anti-endothelial cell antibodies in retinal vasculitis. Curr Eye Res 1992; 11:203.","journal-title":"Curr Eye Res"},{"key":"BF02912462_CR66","first-page":"231","volume":"25","author":"M Soylu","year":"1993","unstructured":"Soylu M, Ersoz TR, Erken E. Circulating corneal epithelial antibodies and immune complexes in immunologic eye disorders. Ann Ophthalmol 1993; 25:231.","journal-title":"Ann Ophthalmol"},{"key":"BF02912462_CR67","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1212\/WNL.41.9.1398","volume":"41","author":"MK Sharief","year":"1991","unstructured":"Sharief MK, Henteges R, Thomas E. Significance of CSF immunoglobulins in monitoring neurologic disease activity in Beh\u00c7et\u2019s disease. Neurology 1991; 41: 1398.","journal-title":"Neurology"},{"key":"BF02912462_CR68","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/bjo.60.1.55","volume":"60","author":"D Tricoulis","year":"1976","unstructured":"Tricoulis D. Treatment of Beh\u00c7et\u2019s disease with chlorambucil. Br J Ophthalmol 1976:60:55.","journal-title":"Br J Ophthalmol"},{"key":"BF02912462_CR69","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","volume":"322","author":"H Yazici","year":"1990","unstructured":"Yazici H, Pazarli H, Barnes CG, T\u00fcz\u00fcn Y, \u00f6zyazgan Y, Silman A, Serdaroglu S, Oguz Y, Yurdakul S, Lovatt GE, Yazici B, Somani S, M\u00fcft\u00fcoglu A. A controlled trial of azathioprine in Beh\u00c7et\u2019s syndrome. N Engl J Med 1990; 322:281.","journal-title":"N Engl J Med"},{"key":"BF02912462_CR70","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/02713689008999414","volume":"9","author":"M Diaz-Llopis","year":"1990","unstructured":"Diaz-Llopis M, Cervera M, Menezo JL. Cyclosporin: A treatment of Beh\u00c7et\u2019s disease: a long-term study. Curr Eye Res 1990; 9[Suppl]:17.","journal-title":"Curr Eye Res"},{"key":"BF02912462_CR71","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0190-9622(91)70156-V","volume":"24","author":"JL Jorizzo","year":"1991","unstructured":"Jorizzo JL, White WL, Wise CM, Zanolli MD, Sherertz EF. Lowdose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarteritis nodosa and Beh\u00c7et\u2019s disease. J Am Acad Dermatol 1991; 24:973.","journal-title":"J Am Acad Dermatol"},{"key":"BF02912462_CR72","first-page":"31","volume":"4","author":"T Hashimoto","year":"1992","unstructured":"Hashimoto T, Takeuchi A. Treatment of Beh\u00c7et\u2019s disease. Curr Opin Rheumatol 1992; 4:31.","journal-title":"Curr Opin Rheumatol"},{"key":"BF02912462_CR73","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(75)80031-6","volume":"11","author":"N Matsumura","year":"1975","unstructured":"Matsumura N, Mizushima Y. Leucocyte movement and colchicine treatment in Beh\u00c7et\u2019s disease. Lancet 1975; 11:813.","journal-title":"Lancet"},{"key":"BF02912462_CR74","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(89)92381-7","volume":"1","author":"K Masuda","year":"1989","unstructured":"Masuda K, Nakajima A, Urayama A, Nakae K, Kogure M, Inaba G. Double masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Beh\u00c7et\u2019s disease. Lancet 1989; 1:1093.","journal-title":"Lancet"},{"key":"BF02912462_CR75","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/art.1780280611","volume":"28","author":"RB Nussenblatt","year":"1985","unstructured":"Nussenblatt RB, Palestine AG, Chan C-C, Mochizuki M, Yancey K. Effectiveness of cyclosporin therapy for Beh\u00c7et\u2019s disease. Arthritis Rheum 1985; 28:671.","journal-title":"Arthritis Rheum"},{"key":"BF02912462_CR76","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-4362.1991.tb05883.x","volume":"30","author":"H Simsek","year":"1991","unstructured":"Simsek H, Dundar S, Telatar H. Treatment of Beh\u00c7et\u2019s disease with indomethacin. Int J Dermatol 1991 ; 30:54.","journal-title":"Int J Dermatol"},{"key":"BF02912462_CR77","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/rheumatology\/27.4.300","volume":"27","author":"URS Davies","year":"1988","unstructured":"Davies URS, Palmer RG, Denman AM. Treatment with acyclovir does not affect orogenital ulcers in Beh\u00c7et\u2019s syndrome: a randomized double blind trial. Br J Rheumatol 1988: 27:300.","journal-title":"Br J Rheumatol"},{"key":"BF02912462_CR78","first-page":"1098","volume":"21","author":"V Hamuryudan","year":"1994","unstructured":"Hamuryudan V, F\u00fcsun M, Sebahattin Y, Mat C, T\u00fcz\u00fcn Y, \u00f6zyazgan Y, Direskeneli H, Akoglu T, Yazici H. Systemic interferon \u03b1-2b treatment in Beh\u00c7et\u2019s syndrome. J Rheumatol 1994; 21:1098.","journal-title":"J Rheumatol"},{"key":"BF02912462_CR79","first-page":"293","volume":"196","author":"J Sanchez-Roman","year":"1996","unstructured":"Sanchez-Roman J, Pulido-Aguilera MC, Castillo-Palma MJ, Ocana Medina C, Toral-Pena A, Lopez-Checa F, Wichmann I. The use of interferon \u03b1-2b in the treatment of autoimmune uveitis (primary or associated with Beh\u00c7et\u2019s disease). Rev Clin Esp 1996; 196:293.","journal-title":"Rev Clin Esp"},{"key":"BF02912462_CR80","doi-asserted-by":"crossref","first-page":"891","DOI":"10.7326\/0003-4819-124-10-199605150-00005","volume":"124","author":"K Yasui","year":"1996","unstructured":"Yasui K, Ohta K, Kobayashi M, Aizawa T, Komiyama A. Successful treatment of Beh\u00c7et\u2019s disease with pentoxifylline. Ann Intern Med 1996; 124:891.","journal-title":"Ann Intern Med"},{"key":"BF02912462_CR81","doi-asserted-by":"crossref","first-page":"S 31","DOI":"10.1006\/clin.1996.0139","volume":"80","author":"CC Whitacre","year":"1996","unstructured":"Whitacre CC, Gienapp IE, Meyer A, Cox KL, Javed N. Treatment of autoimmune disease by oral tolerance to autoantigens. Clin Immunol Immunopathol 1996; 80:S 31.","journal-title":"Clin Immunol Immunopathol"}],"container-title":["International Journal of Clinical &amp; Laboratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02912462.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02912462\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02912462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T16:15:50Z","timestamp":1684426550000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02912462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,12]]},"references-count":81,"journal-issue":{"issue":"2-4","published-print":{"date-parts":[[1997,12]]}},"alternative-id":["BF02912462"],"URL":"https:\/\/doi.org\/10.1007\/bf02912462","relation":{},"ISSN":["0940-5437","1434-4467"],"issn-type":[{"value":"0940-5437","type":"print"},{"value":"1434-4467","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,12]]}}}